Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
Tweet
Share
E-mailSAN FRANCISCO, Oct. 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced it will report results for the third quarter ended September 30, 2019, on Wednesday, November 6, 2019, after NASDAQ market close.
UNITY will not conduct a conference call in conjunction with the financial results press release.
About UNITYUNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.
Investors Endurance Advisors Peter Rahmer [email protected] Media Canale Communications Jason Spark [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Comstock Metals Brings Fully Integrated Industry-Scale Solar Recycling System Online
- Euna Solutions Named to 2026 AI 50 for Delivering Measurable Financial Impact to Public Sector Organizations
- Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
